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ABSTRACT 
 
 
 
Thompson, Carrie Marie.  M.S., Department of Neuroscience, Cell Biology, and 
Physiology, Wright State University, 2010.  Presynaptic Regulation of Carotid Body 
Type I Cells by Histaminergic and Muscarinic Receptors. 
 
 
 
 Type I cells are one of two main cell types located within the carotid body.  These 
cells respond to hypoxia, hypercapnia, and acidosis by releasing excitatory and 
inhibitory neurotransmitters.  This causes increased firing of the carotid sinus nerve 
and restores blood gas levels to their physiological values.  While previous studies have 
shown whether individual neurotransmitters are excitatory or inhibitory, this work 
demonstrates how the interplay between two neurotransmitters may potentially shape 
the output of the carotid body.  Histamine, which has previously been shown to have no 
effect on intracellular Ca2+ in type I cells, may function to modulate the actions of an 
excitatory neurotransmitter such as acetylcholine.  Using Ca2+-imaging techniques, this 
work shows that histamine inhibits the acetylcholine muscarinic receptor-induced rise 
in intracellular Ca2+.  Histamine, acting on the Gi-coupled H3 receptor, may exert its 
actions by inhibiting the activation of adenylate cyclase and therefore reducing levels of 
cAMP.  The observed inhibition of muscarinic Ca2+ signaling seems independent of 
protein kinase A (PKA), as two PKA inhibitors did not mimic the inhibition.  Data 
suggest that Gi-coupled receptor activation may inhibit muscarinic Ca2+ signaling in 
type I cells by the inhibition of Exchange Proteins Activated by cAMP (Epac).   
Some of this work has been published previously: 
 
Thompson, C. M., et al (2010). Neuroscience Letters 471, 15-19 
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I:  INTRODUCTION 
 
ANATOMY 
 The carotid bodies (CB) are small organs located at the bifurcation of the 
common carotid artery in mammals (Fig. 1 A).   These organs function as the primary 
peripheral chemoreceptors to modulate breathing in regards to changes in levels of 
arterial PO2, PCO2, and [H+].   In response to hypoxia, hypercapnia, or acidosis, the CB 
releases a series of neurotransmitters that eventually lead to hyperventilation. 
 The CB has duel innervation.  First is the carotid sinus nerve (CSN), a branch of 
the glossopharyngeal nerve, cranial nerve IX, whose cell bodies lie in the petrosal 
ganglion.  The CSN afferently projects to the nucleus tractus solitarius of the medulla 
(Finley and Katz, 1992).  The superior cervical ganglion, via the ganglioglomerular 
nerve, innervates the CB as well.  The ganglioglomerular nerve is the efferent 
component that functions to primarily innervate the blood vessels controlling the blood 
flow to the CB (Gonzalez et al, 1994).  A large area of the CB is covered with blood 
vessels (McDonald, 1981) with up to a third of its volume being blood vessels (de Castro 
and Rubio, 1968).  The CB is one of the most richly supplied organs in the body with 
perfusion from branches of the common carotid artery, mainly via the internal carotid 
body artery (Gonzalez et al, 1994).  The chemosensory organ is drained via tributaries 
of the internal jugular vein (Gonzalez et al, 1994). 
 The CB parenchyma consists of two major cells types:  type I (glomus) cells and 
type II (sustentacular) cells (Fig. 1 B).  The majority of cells, type I cells, are the sensory 
receptors responsible for detecting levels of arterial PO2, PCO2, and [H+]  
 
 2 
Figure 1  
A schematic demonstrating the anatomy of the carotid body.  A.  The carotid body 
shown at the bifurcation of the common carotid artery (CC), lying on the internal 
carotid artery (IC) across from the external carotid artery (EC).  B.  Type I cells 
enveloped by type II cells in the carotid body.  Type I cells are innervated by the carotid 
sinus nerve (CSN). 
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(Stea and Nurse, 1991, Heymans et al, 1930).  When PO2 or pH falls or PCO2 gets too 
high, the type I cells respond by releasing neurotransmitters that cause an increase in 
action potential frequency along the CSN.  In addition to their connections with nerve 
endings, type I cells also have gap junction connections with one another (Gonzalez et 
al, 1994).  This allows for cellular communication among type I cells.  Type II cells have 
a more glial-like function.  The processes of these cells surround the junctions formed 
by type I cells and nerve endings (Prabhakar, 2000) and may also serve to phagocytize 
damaged nerve endings (McDonald, 1981).   However, these cells lack any excitable 
properties.  Some studies have shown other functions of the type II cells.  For example, 
Pardal et al (2007) found that the type II cells serve as a stem cell population for type I 
cells.  
 
HISTORY 
 Jacques-BénigneWinslow first described the carotid bodies in the 1600’s 
(Kellogg, 1981).  Without a prior classification and improving technology, another 
anatomist, Hubert Luschka, classified the CB as a gland in 1862 (McDonald, 1981).  
Much more detailed information became available in the 1920’s due to the work of 
Fernando de Castro.  The CB was initially considered neurosecretomotor, but de Castro 
(1926) discovered that the cell bodies of the CSN lay within the petrosal sensory 
ganglion thus proving that the CB was sensory.  Originally thought to be a gland, de 
Castro (1928) concluded that the CB was in fact a sensory organ.  He continued his 
work by hypothesizing that the CB functioned to sense changes in arterial blood 
composition, such as a decrease in PO2 or pH or an increase in PCO2, and that the type I 
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cells functioned as the chemosensors (de Castro, 1928).   It was another researcher, 
Corneille Heymans, who proved that these changes in blood composition acted on the 
chemosensors in the CB to elicit a response.  His experimental design consisted of two 
living canines attached via parabiosis, one canine’s head was connected by arteries of 
the second canine (Fig. 2).  In his experiment the second canine was exposed to hypoxia, 
and the first canine began to hyperventilate (Heymans et al, 1930).  For this work, 
Heymans won the Nobel Prize in Physiology or Medicine in 1938 (De Castro, 2009). 
 
TYPE I CELL TRANSDUCTION  
 Carotid body type I cells respond with depolarization to adverse chemostimuli, 
such as hypoxia, due to the inhibition of chemosensitive K+ channels (Lopez-Barneo et 
al, 1988).  In the rat there are two different types of chemosensitive K+ channels, the 
high-conductance Ca2+ -dependent K+ channels and the TASK-like background K+ 
channels (Peers, 1990, Buckler et al, 2000, Buckler, 1997).  The membrane 
depolarization results in voltage-gated Ca2+ entry causing a rise in intracellular calcium  
([Ca2+]i) (Buckler and Vaughan-Jones, 1994) and consequential neurotransmitter 
release (Gonzalez et al, 1994).  Exactly what causes the K+ channels to be inhibited in 
the first place is debatable and has given rise to two different chemotransduction 
hypotheses:  the membrane hypothesis and the mitochondrial hypothesis. 
 
MEMBRANE HYPOTHESIS 
 The membrane hypothesis is based on the fact that during hypoxia, plasma 
membrane K+ channels are inhibited (Lopez-Barneo et al, 1988) resulting in type I 
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Figure 2 
Heymans’ experiment in which two living canines were attached via parabiosis.  Canine 
A was connected to Canine B through the vessels of their necks and thoracic cavities.  
Canine A was subjected to hypoxia, and Canine B responded by hyperventilating.   
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cell depolarization due to voltage-gated Ca2+ channels.  The type of K+ channel involved 
varies among species (Prabhakar, 2000).  This introduction will focus only on two 
classes of K+ channels that are chemosensitive in the rat. 
 The first class, high-conductance Ca2+ -dependent K+  (BK) channels, are open at 
resting membrane potential; therefore, they may be able to regulate action potentials of 
cells (Lahiri et al, 2006).   BK channels are thought to play a vital role in regulating type 
I cells during hypoxic responses (Peers, 1990).  The enzyme hemeoxygenase-2 (HO-2) 
is the suggested oxygen sensor (Williams et al, 2004).  HO-2 causes the production of 
carbon monoxide (CO), which tonically activates the BK channels (Williams et al, 2004, 
Kemp, 2005).  During a hypoxic challenge CO levels drop to a level that can no longer 
sustain the activation of BK channels (Kemp, 2005).  However, the fact that HO-2 null 
mice demonstrate similar CB output in response to hypoxia as control mice shows that 
HO-2 may not be the sole oxygen sensor (Ortega-Saenz et al, 2006).  
 The BK channels have also been studied by pharmacological and patch-clamp 
methods.  Only one BK channel blocker, ChTX, has been shown to depolarize type I cells  
(Wyatt and Peers, 1995).  Using the patch clamp technique it has been shown that 
hypoxia affects the BK channels depending on the exact patch-clamp method that is 
used.  With whole-cell and inside-out configuration, BK channels of type I cells are 
sensitive to hypoxia (Riesco-Fagundo et al, 2001).  However, when the outside-out 
configuration is applied, the same channels are no longer sensitive to hypoxia (Wyatt 
and Peers, 1995).  This indicates that something is lost in the cytoplasm due to the 
various patch-clamping method that is used, so the membrane alone is probably not 
responsible for type I cell depolarization. 
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 The second category of oxygen-sensing K+ channels that were found to be open 
at resting membrane potential in type I cells are the Twik-related acid sensing K+ 
(TASK-like) channels (Lahiri et al, 2006).  These channels were first described as 
voltage-insensitive background K+ channels (Buckler, 1997), and upon further research, 
these channels were found to be similar to TASK channels and thusly named TASK-like 
channels (Buckler et al, 2000).  Recently, research has shown that the TASK-like 
channels expressed in type I cells are TASK-1, TASK-3 and a TASK-1/TASK-3 
heteromer, which is responsible for the majority of oxygen-sensing background K+ 
current (Kim et al, 2009).  Hypoxia inhibited TASK channels leading to depolarization in 
CB type I cells and consequent rise in [Ca2+]i (Buckler et al, 2000, Buckler, 1997).  
Finally, mitochondrial inhibitors and uncouplers inhibited TASK channel currents.  The 
fact that these channels are sensitive to mitochondrial metabolism implies that these 
channels may detect blood O2 levels by a mitochondrial mechanism. Thus, functional 
mitochondria may be required for hypoxic inhibition of the chemosensitive TASK-like 
channels in type I cells (Buckler et al, 2006).  
 
MITOCHONDRIAL HYPOTHESIS   
 The process of oxidative phosphorylation, occurring in the mitochondria, 
requires oxygen as the final electron acceptor to produce ATP via cellular respiration.  
In times of low oxygen, or hypoxia, this process will slow or be halted.  The fact that 
oxygen is central to this process allowed for the development of the mitochondrial 
hypothesis of type I cell transduction (Lahiri et al, 2006).   Mills and Jobsis (1972) 
proposed that a particular mitochondrial complex in type I cells must have an unusually 
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low affinity for oxygen to allow for oxygen sensing.  It was also found that during 
hypoxia the mitochondrial membrane of oxygen-sensing type I cells depolarizes, but in 
non-oxygen-sensing chromaffin cells of the adrenal gland and sensory neurons of the 
dorsal root ganglion, the mitochondrial membrane does not depolarize until anoxia 
(Duchen and Biscoe, 1992b, Duchen and Biscoe, 1992a).  This information provides 
further support for the mitochondrial hypothesis and indicates that type I cell 
mitochondria respond to hypoxia in a specialized manner.   
 Mitochondrial electron transport chain inhibitors and uncouplers as well as ATP 
synthase inhibitors have been used pharmacologically to mimic the effects of hypoxia.  
This is seen by an increase in [Ca2+]i in type I cells which causes a release of 
neurotransmitters that act post-synaptically on the CSN.   Heymans et al (1931) used 
cyanide, a known mitochondrial IV complex inhibitor, to increase CB activity.  
Oligomycin, an ATP synthase inhibitor, was used to show a link between mitochondrial 
function and the increased firing activity of the CSN due to hypoxia is via the inhibition 
of ATP mitochondrial production (Mulligan et al, 1981, Wyatt and Buckler, 2004).  
Inhibitors of complex I, complex III, and complex IV caused an increase in [Ca2+]i as well 
as inhibition of background K+ channels (Wyatt and Buckler, 2004).  These 
mitochondrial inhibitors also prevent the type I cells from further responding to 
hypoxia suggesting a common mechanism that mediates both processes (Mulligan et al, 
1981, Wyatt and Buckler, 2004). 
 How the mitochondria of type I cells couple to the K+ channels of the plasma 
membrane is not exactly known.  One possible mechanism is that ATP regulates TASK-
like K+ channels such that when ATP levels decrease, the K+ channels are inhibited 
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(Varas and Buckler, 2006).  Another hypothesis in this matter involves AMP-activated 
protein kinase (AMPK).  Due to the decreased ATP levels, an increase in the AMP/ATP 
ratio activates AMPK, which in turn inhibits the K+ channels.  The inhibition of the K+ 
channels then depolarizes the cell activating the voltage-dependent calcium channels.  
The influx of calcium causes the release of neurotransmitters from the type I cells of the 
CB (Evans, 2006). 
 
NEUROTRANSMITTERS 
 This thesis will focus on the interaction of neurotransmitters at the level of the 
carotid body type I cells.  The rise in intracellular calcium ([Ca2+]i) during chemostimuli 
causes the release of a series of neurotransmitters.  The neurotransmitters can either 
act presynaptically (in a paracrine or an autocrine fashion) or postsynaptically acting 
on the CSN (Fig. 3).  The balance between the release of excitatory and inhibitory 
neurotransmitters determines the nature of the response of the CSN. 
 
DOPAMINE 
 Dopamine (DA) is one of the monoamines produced, stored, and released by the 
CB during hypoxia.  It was once considered to be the main neurotransmitter of  
the CB since DA is found at its highest levels peripherally in the CB (Gonzalez et al, 
1994).  To produce DA, type I cells require the enzymes tyrosine hydroxylase (TH).  
Type I cells also contain VMAT 1 and VMAT2 for the storage of DA.  In addition, the 
proteins SNAP25 and syntaxin1 were shown in type I cells as they are required for the 
release of DA (Koerner et al, 2004). 
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Figure 3 
A schematic demonstrating the release of neurotransmitters from carotid body type I 
cells.  Neurotransmitters released from type I cells can bind to receptors on the surface 
of the cell releasing them, on the surface of neighboring type I cells, or on afferent fibers 
of the carotid sinus nerve. 
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 DA acts on D2 receptors found on the surface of type I cells and the CSN (Dinger 
et al, 1981, Mir et al, 1984).  During hypoxic challenges the D2 receptor agonist inhibited 
the expected rise in [Ca2+]i; however, once the D2 receptor antagonist was applied, the 
rise in [Ca2+]i was restored (Carroll et al, 2005).  This indicates that DA is inhibitory pre-
synaptically in most species of animals (Jiang and Eyzaguirre, 2004).   In D2 knockout 
mice the action potential frequency of the CSN was lowered compared to wild-type 
mice indicating that DA is probably not essential to CB function, but it plays some role 
in shaping the CB output (Prieto-Lloret et al, 2007).  It should be noted that while DA is 
considered to be inhibitory in most species, the rabbit is the exception; DA has 
excitatory effects on the CSN (Iturriaga et al, 2009).   
 
SEROTONIN 
 The second monoamine localized in the CB is serotonin (5-HT).   5-HT5a 
receptors are expressed in the CB, PG, and SCG meaning that serotonin may have effects 
both pre- and post-synaptically (Wang et al, 2000).  Additionally, 5-HT2 receptors, Gq-
coupled receptors, are located on type I cells (Zhang et al, 2003).  Application of 
serotonin caused the depolarization of type I cells acting on 5-HT2 receptors.  Protein 
kinase C (PKC), which is activated during Gq-coupled receptor stimulation, inhibits 
background K+ channels accomplishing the depolarization (Zhang et al, 2003). 
 Zhang discovered several different effects that are accomplished using the 5-
HT2, PKC-mediated pathway in the CB (2003).  First, it was discovered that the 
spontaneous activity seen in type I cell clusters is due to serotonin acting in an 
autocrine / paracrine mode, and that serotonin is responsible for the presynaptic 
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modulation of type I cell transduction during hypoxia.  Moreover, the spontaneous 
activity seen postsynaptically on afferent petrosal ganglion neurons is due to serotonin 
acting presynaptically on type I cells causing the release of the excitatory 
neurotransmitters acetylcholine and ATP (Zhang et al, 2003).  Taken together, these 
experiments demonstrate the role of serotonin in a positive feedback loop that 
modulates the excitatory effects seen both pre- and post-synaptically in the CB.   
 
ATP 
 Originally thought to be the main excitatory neurotransmitter released from the 
CB, the role of acetylcholine (ACh) has been debated for some time (McQueen, 1977, 
Donnelly, 2009, Dasso et al, 1997, Wyatt and Peers, 1993).  Some of the debate lies in 
the fact that when cholinergic receptors are blocked, the petrosal ganglion nerves still 
depolarize during a hypoxic challenge (Zhong et al, 1997, Nurse and Zhang, 1999, Zhang 
et al, 2000).  Using a co-application of a blocker of P2 purinoceptor, an ATP receptor, 
and a cholinergic receptor blocker, researchers were able to completely abolish the 
hypoxic-induced depolarization of the petrosal ganglion nerves (Zhang et al, 2000).  
This reflects the co-release of two main excitatory neurotransmitters in CB 
transduction, ACh and ATP. 
 During a hypoxic challenge, ATP is released from the CB (Buttigieg and Nurse, 
2004).  ATP acts on P2X receptors with the specific P2X2 and P2X3 subunits (Zhang et al, 
2000, Prasad et al, 2001).  The two subunits can form either homomeric or heteromeric 
P2X receptors (Rong et al, 2003).  Using knockout mice, Rong was able to show that 
P2X2-/- and P2X2/P2X3Dbl -/- mice had a decreased ventilatory response to hypoxia 
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compared to their wild-type littermates.  Additionally, the two knockouts groups also 
showed a significant decrease in CSN activity during a hypoxic challenge compared to 
their wild-type littermates (Rong et al, 2003).  Taken with the fact that P2X3-/- mice 
showed no difference compared to the wild-type animals to a hypoxic challenge, P2X2 
subunits are thought to be vital to the CB chemotransduction in response to hypoxia 
(Rong et al, 2003).  
 Immunohistochemical staining and pharmacological techniques have shown that 
P2X2 and P2X3 subunits are located in the carotid body but not specifically on type I cells 
in both rats and mice (Zhang et al, 2000, Prasad et al, 2001, Rong et al, 2003).  
Nonetheless, the receptors containing the two subunits are found postsynaptically on 
the afferent terminals closely associated with type I cell clusters and on petrosal 
ganglion neurons (Prasad et al, 2001, Rong et al, 2003).   The location of purinergic 
receptors in the CB-CSN preparation explains why the application of ATP did not cause 
a rise in [Ca2+]i  in type I cells (Xu et al, 2003) but did cause the depolarization of the CSN 
(Rong et al, 2003). 
 Moreover, ATP also acts on P2Y receptors, which are located on both type I and 
type II cells (Xu et al, 2003, Xu et al, 2005).  Its action on type I cells, via P2Y1 receptors, 
is to inhibit the rise in [Ca2+]i induced by hypoxia (Xu et al, 2005).  Therefore, ATP is 
excitatory postsynaptically, while inhibitory presynaptically possibly acting as a 
negative feedback regulator of type I cells.  Interestingly, ATP caused a rise in [Ca2+]i in 
type II cells, the glial-like cells found in close association with type I cells found in CB, 
acting on P2Y2 receptors (Xu et al, 2003).  Since ATP is released from type I cells during 
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hypoxia, and type I and type II cells are so closely associated, it is hypothesized that the 
type II cells may act in some type of modulatory role during a hypoxic response. 
 
ACETYLCHOLINE 
 Acetylcholine (ACh) is yet another neurotransmitter released from the carotid 
body due to a chemostimulus (Eyzaguirre and Zapata, 1968).  As previously stated, it is 
co-released with ATP acting as one of the main excitatory neurotransmitters of the CB 
(Zhang et al, 2000).  Before it was discovered that both ATP and ACh are co-released 
acting as excitatory transmitters, the role of ACh in CB transduction was debated.  Some 
results could not support the excitatory role of ACh in the actions of the CB (McQueen, 
1977, Donnelly, 2009).  However, a vast amount of research has been able to clearly 
demonstrate an excitatory role for ACh.  Some of the various actions in 
chemotransduction via ACh include membrane depolarization of type I cells (Wyatt and 
Peers, 1993, Nurse and Zhang, 1999), increase in [Ca2+]i  in type I cells(Jiang and 
Eyzaguirre, 2004, Dasso et al, 1997), and depolarization of the CSN (Nurse and Zhang, 
1999, He et al, 2005).   
 Research has shown that type I cells possess the proteins necessary to produce, 
store, and degrade ACh.  Choline acetyltransferase (ChAT), the rate-limiting enzyme 
required for ACh synthesis, vesicular ACh transporter (VAChT), the protein responsible 
for mobilizing ACh into synaptic vesicles, and acetylcholinesterase (AChE), the enzyme 
that functions to degrade ACh, are all localized in type I cells (Nurse and Zhang, 1999, 
Wang et al, 1989).  In addition autonomic microganglion cells also supply type I cells 
with much of its ACh, specifically in the rat CB (Gauda et al, 2004). 
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 Acetylcholine activates two different cholinergic receptors:  nicotinic and 
muscarinic ACh receptors.  Both types of receptors are found on the surface of type I 
cells and postsynaptically on the CSN (Wyatt and Peers, 1993, Shirahata et al, 2007, 
Dinger et al, 1991, Zhong and Nurse, 1997, Shirahata et al, 2004).  Stimulation of both 
receptors on the surface of type I cells results in an increase in [Ca2+]i (Dasso et al, 1997, 
He et al, 2005). 
 Nicotinic receptors are ligand-gated ion channels, and their activation opens 
voltage-gated calcium channels.  Binding of a nicotinic agonist to the receptor increases 
the cell membrane’s permeability to calcium resulting in an increase in [Ca2+]i within 
milliseconds.  When these receptors were activated in a calcium-free medium, no rise in 
[Ca2+]i was seen indicating that the source of calcium freed by these receptors is 
extracellular (Dasso et al, 1997). Activation of nicotinic receptors is responsible for 
much of the increase in [Ca2+]i (Shirahata et al, 1997).  Calcium responses to nicotinic 
agonists were transient as the calcium levels returned to baseline levels while still in 
the presence of the agonist indicating nicotinic receptor desensitization (Dasso et al, 
1997).  
 Much of this thesis will focus specifically on the regulation of muscarinic 
receptor signaling in type I cells.  There are five sub-types of muscarinic receptors, the 
other cholinergic receptor; all of which are G protein-coupled.  It is commonly accepted 
that the odd-numbered muscarinic receptors (M1, M3, and M5) are Gq-coupled, and that 
the even-numbered muscarinic (M2 and M4) receptors are Gi-coupled (Ishii and Kurachi, 
2006).  Activation of the odd-numbered receptors will activate phospholipase C (PLC), 
which causes the cleavage of phosphatidyl 4,5-biphosphate (PIP2) into diacylglycerol 
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(DAG) and inositol 1,4,5-trisphosphate (IP3).  DAG enables the activation of protein 
kinase C (PKC) while IP3 binds to intracellular receptors that cause the release of 
calcium from internal stores.  The released calcium can further activate PKC.  PKC has 
been shown to inhibit BK channels in the membranes of rat type I cells leading to 
membrane depolarization (Peers and Carpenter, 1998).  Additionally, the activation of 
G q coupled receptors inhibits TASK channels, which would also lead to cell 
depolarization (Chen et al, 2006).  Furthermore, the activation of muscarinic receptors 
on rat type I cells has been shown to inhibit TASK channels via a PLC/PKC-mediated 
mechanism (Ortiz and Varas, 2010).  The inhibition of these K+ channels would cause 
the type I cells to depolarize possibly due to the activation of an odd-numbered, Gq-
coupled muscarininc receptor.   
 The even-numbered receptors are negatively coupled to adenylate cyclase and 
will prevent the accumulation of cAMP and calcium and inhibit the activation of protein 
kinase A (PKA).   The activation of PKA has been shown to inhibit TASK channels, so by 
inhibiting PKA activation, the cell membrane may not undergo depolarization and 
therefore voltage-gated Ca2+ entry would not occur (Xu et al, 2007). 
 Due to the high level of homology between the five subtypes, the receptor 
subtypes in the CB and petrosal ganglion of most species have not yet been classified 
(Caulfield and Birdsall, 1998).  However, in the cat CB, the M1 and M2 receptors have 
been localized to type I cells by using RT-PCR and immunocytochemistry as well as 
pharmacologically, but the M2 receptors were not found on petrosal ganglion nerves 
while the M1 receptors were (Shirahata et al, 2004, Fitzgerald et al, 1997).  During the 
application of a M1 antagonist during a hypoxic challenge, there was a decrease in post-
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synaptic activity; the opposite was found during the application of a M2 antagonist 
(Fitzgerald et al, 1997).  These results indicate that activation of the M1 receptor 
stimulates type I cells, and M2 receptor activation inhibits them, and they further 
support the idea that odd-numbered receptor activation is excitatory while even-
numbered receptor activation is inhibitory.  Non-specific muscarinic receptor activation 
increases [Ca2+]i by causing a calcium influx from extracellular sources just as nicotinic 
receptor activation does, but additionally, muscarinic receptor activation releases 
calcium from intracellular stores (Dasso et al, 1997).  This is most likely due to the 
activation of one of the Gq- coupled, odd-numbered muscarinic receptors.   
 The ratio of nicotinic to muscarinic receptors may also play a role in determining 
if ACh is excitatory or inhibitory in CB function, and this may be a reason why certain 
researchers could not support the excitatory role of ACh.   For example, Hirano’s 
research showed that in the rabbit CB, ACh inhibited CSN activity, and in the cat CB, ACh 
stimulated CB activity (Hirano et al, 1992).  It was found that the rabbit CB had a 12:1 
ratio of muscarinic to nicotinic receptors.  Conversely, in the cat, the ratio of nicotinic to 
muscarinic receptors in the CB was 2:1 (Hirano et al, 1992).  Even though the specific 
muscarinic receptor subtypes were not identified, it is assumed that it was a Gi-coupled 
receptor, which would inhibit activity.  This data shows another marked difference in 
CB actions among species. 
 Besides being released via reactions to various chemostimuli, ACh is 
spontaneously released from type I cells (Zhong et al, 1997, Nurse and Zhang, 1999, 
Zhang et al, 2000).  Resulting from this spontaneity is a spiking activity seen 
postsynaptically on the CSN (Nurse and Zhang, 1999, Wyatt et al, 2007).  The excitatory 
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actions are most likely due to the activation of nicotinic receptors since the use of the 
nicotinic antagonist mecamylamine inhibited most of the spontaneous activity (Nurse 
and Zhang, 1999).  Furthermore, the spontaneously released ACh will presumably act in 
an autocrine or paracrine fashion on type I cells since the type I cells have cholinergic 
receptors.   
 
HISTAMINE 
 Histamine is yet another transmitter found to be associated with CB function.  
Koerner et al (2004) found that the proteins required to produce, store, and release 
histamine are found in type I cells.  Histidine decarboxylase, the rate-limiting enzyme 
for histamine production, is expressed throughout the CB.  The vesicular monoamine 
transporters, VMAT1 and VMAT2, were also found in type I cells.  Finally, SNAP25 and 
syntaxin1 were shown to be in type I cells (Koerner et al, 2004).   
 There are four receptor subtypes in which histamine acts upon:  H1, H2, H3, and 
H4.  Several groups have localized the various receptors.  All four receptors were found 
on the surface of type I cells (Koerner et al, 2004, Burlon et al, 2009, Lazarov et al, 
2006).  Additionally, H1 and H3 receptors were located on petrosal ganglion neurons 
and in portions of the NTS (Lazarov et al, 2006).  The four histamine receptor subtypes 
are coupled to G-proteins, which make use of second messenger systems.   
 The H1 receptor is coupled to the G q family of G-protein coupled receptors.  
Activation of H1 receptors activates phospholipase C, which in turn, causes the cleavage 
of phosphotidylinositol 4,5-biphosphate (PIP2) into diacylglycerol (DAG) and inositol-
1,4,5-trisphosphate (IP3) (Hill et al, 1997).  DAG causes the activation of protein kinase 
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C (PKC).  IP3 binds to intracellular receptors of membrane-bound organelles causing a 
release of calcium from these intracellular stores.  The increase in [Ca2+]i also further 
stimulates the activation of PKC.   
 H2 receptors are coupled to adenylate cyclase by way of Gs receptor protein, and 
when stimulated, cause the accumulation of cAMP (Hill et al, 1997).  cAMP then 
activates protein kinase A (PKA) and calcium channels allowing calcium to enter the 
cell.  Furthermore, a PKA-dependent pathway was shown to inhibit TASK-like channels 
in type I cells, channels responsible for maintaining resting membrane potential in type 
I cells, resulting in cell depolarization and increase in [Ca2+]i  (Xu et al, 2007). 
 Both H3 and H4 receptors are negatively coupled to adenylate cyclase via Gi 
coupled proteins, and therefore, oppose the actions of H2 receptors.  By preventing the 
activation of adenylate cyase, there is no resulting cAMP accumulation, and therefore, 
no calcium or PKA accumulation.  H3 receptors are thought to be auto-receptors that 
function to regulate the synthesis and release of histamine and other transmitters 
(Arrang et al, 1985, Arrang et al, 1983).  Recent research has shown that the G  
subunit of H3 receptors inhibits voltage-dependent calcium channels, which would 
further prevent calcium influx (Morrey et al, 2008). 
 As reported, histamine is released during hypoxia (Koerner et al, 2004); 
however, the role of histamine during hypoxia has not been exactly pinpointed.  In the 
working heart-brainstem preparation (WHBP) of rats, the CB was perfused with NaCN 
and H1 and H3 agonists.  All three experiments’ effects showed an increase in phrenic 
nerve activity, which would cause an increase in respiration, indicating an excitatory 
role for histamine (Lazarov et al, 2006).  Recall that both H1 and H3 receptors are also 
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found on the surface of petrosal ganglion neurons and within the NTS (Lazarov et al, 
2006), so the excitatory effects of histamine may be due to the activation of histamine 
receptors in any of these three locations.  The injection of histamine may have also 
caused the afferent artery to constrict, which would induce hypoxia.  As a result, 
histamine may have appeared to be an excitatory transmitter.  A third possibility is that 
histamine may be potentiating the effects of excitatory neurotransmitter, such as 
acetylcholine, that is released from the carotid body. 
 Using in vitro CB and petrosal ganglion preparations in cats, Del Rio 
demonstrated that exogenously applied histamine perfused and superfused over the 
preparation in cats caused an increase in CSN firing frequency, but when histamine was 
applied to isolated petrosal ganglia cell bodies, there was no effect on the CSN.  In this 
same study the superfusion of the H1 receptor antagonist reduced the CSN firing 
frequency, while the H3 receptor antagonist potentiated the effect of histamine on the 
firing frequency of the CSN (Del Rio et al, 2008).  This supports the idea that histamine 
is presynaptically excitatory.    
 While the previously discussed research implicated histamine as an excitatory 
transmitter, Burlon et al (2009) found that histamine had no effect on isolated CB type I 
cells in rats.  Histamine and H1, H2, and H3 agonists did not raise [Ca2+]i.  This data does 
not support Del Rio’s findings that histamine is an excitatory presynaptic 
neurotransmitter (Burlon et al, 2009). 
 The differences in results may be due to differences in species.   However, Del 
Rio assumed that histamine was excitatory presynaptically because his research found 
no effect of histamine on the petrosal ganglion cell bodies, but he did not apply 
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histamine to CSN nerve endings within the carotid body.  The excitatory effects of 
histamine are most likely post-synaptic as seen with Lazarov’s experiments. 
 
HYPOTHESIS 
 It has been shown that activation of muscarinic receptors is excitatory (Dasso et 
al, 1997); however, the response due to the activation of histamine receptors is not yet 
fully understood (Burlon et al, 2009, Lazarov et al, 2006).  This thesis will test the 
hypothesis that activation of histamine receptors will modulate the signaling properties 
of muscarinic receptors.  Potentiation of the muscarinic response could partially explain 
the findings of Lazarov et al (2006) that histamine is excitatory in the carotid body. 
  
SUMMARY 
 The carotid bodies, located at the bifurcation of the common carotid artery, 
serve as the primary peripheral chemoreceptors.  Of the two different cell types located 
in the carotid body, type I cells act as the chemosensors, while the type II cells primarily 
function as glial cells.  Type I cells detect changes in arterial blood gas and pH, and when 
non-homeostatic levels are sensed, depolarize resulting in a release of 
neurotransmitters.  The neurotransmitters can either modulate the release of other 
neurotransmitters being released from type I cells, or they can act postsynaptically on 
the carotid sinus nerve.  Output from the brainstem causes hyperventilation to restore 
arterial blood gas and pH levels to homeostasis. 
 The focus of this thesis is to determine the interplay between muscarinic and 
histamine receptor activation.  This work will test whether or not histamine can 
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modulate the Ca2+ response to muscarinic receptor activation.  Finally, this work aims 
to characterize any observed modulation using pharmacological methods.   
 
II:  MATERIALS AND METHODS 
 
 All studies described in this paper were performed in accordance with protocols 
approved by the Wright State University Institutional Laboratory Animal Care and Use 
Committee (IACUC).  These protocols are in accordance with the National Institute of 
Health guide for the care and use of laboratory animals (NIH publications No. 80-23) 
revised 1996. 
 
DISSECTION AND DISSOCIATION OF NEONATAL RAT CAROTID BODY TYPE I CELLS 
 On each experimental day, two or three neonatal Sprague Dawley rats (aged 10-
20 days) were placed into an induction chamber supplied with 4.5% isofluorane and 
oxygen to anesthetize the animal.  After the rat became unconscious it was moved from 
the induction chamber and placed so that a gas mask supplying the mixture of gases 
was continuously supplied to the animal.  To ensure that the animals were completely 
unconscious, the foot pinch withdrawal reflex was tested.  Only after it was ensured that 
the animal was completely asleep were the following steps taken:  The rat’s forelegs 
were taped down and an incision was made along the sternum exposing the underlying 
subcutaneous fascia.  Then the salivary glands as well as muscle lying lateral to trachea 
were removed using fine forceps (Moria, Fine Science Tools, USA) to expose the 
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bifurcation of the common carotid artery deep to those structures.  Great care was 
taken to ensure that none of the surrounding blood vessels were damaged. 
 Using a dissection microscope (Omâna, Japan) under low magnification, the fat 
and fascia were removed to further expose the bifurcation of the common carotid 
artery.  First the overlying glossopharyngeal nerve was removed followed by the 
retraction of the occipital carotid artery to expose the carotid body.  The carotid body 
was almost always found anchored in connective tissue to the internal carotid artery.  
The organ was then carefully removed with the forceps and placed directly into ice-
cold, oxygenated, Dulbecco’s phosphate buffered saline (DPBS) without Ca2+ or Mg2+ 
(Sigma).  Following removal of the carotid body, the rats were euthanized by 
decapitation while still deeply anesthetized.  The bodies were disposed of according to 
the Lab Animal Research specifications.  In the lab, the remaining connective tissue was 
removed from the four to six carotid bodies using the fine forceps underneath the 
Omâna dissecting microscope.   
 The cleaned carotid bodies were then placed in a digestive enzyme solution 
(0.4mg ml-1 collagenase type I, 220u mg-1  (Worthington Biochemical Corporation), 0.2 
mg ml-1 trypsin type I, 8550 BAEE u mg-1 (Sigma) in DPBS with low CaCl2 (86 M) and 
MgCl2 (350 M) for 20 minutes at 37° C to digest the connective tissue holding the 
carotid body together.  The carotid bodies were teased apart and incubated at 37 °C for 
7 minutes.  Following the last digestion, the carotid body tissue was removed from the 
Petri dish using a fire-polished, silanized (Sigmacote, Sigma) Pasteur pipette and placed 
into a test tube.  The tissue was triturated and centrifuged at 110g for 5 minutes.  After, 
the cells were resuspended in tissue culture medium (Ham’s F12 (Sigma) supplemented 
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with 10% heat inactivated fetal bovine serum (Biowest), centrifuged again for 5 
minutes at 110g, resuspended in tissue culture medium, and plated onto 12 mm2 poly-
d-lysine (0.01% w/v) coated glass coverslips for imaging.  Coverslips were placed in Petri 
dishes and maintained at 37 °C in a humidified, 5% CO2/air incubator.  Cells were 
allowed to adhere to the coverslips for 2 hours, and all cells were used for 
experimentation within 8 hours. 
 
FURA-2AM 
 Fura-2AM is a molecular probe that is used to determine intracellular calcium 
concentrations through fluorescence. (Fig. 4).  The acetoxymethyl ester portion of the 
probe allows for the molecule to diffuse easily through the plasma membrane of the 
cell, enabling researchers to avoid using more invasive techniques for loading.  Once 
inside the cell, the AM portion is cleaved off by the cell’s esterases, and the cell-
impermeant fluorescent indicator is left behind.  Upon binding Ca2+, Fura-2 exhibits an 
absorption shift that can be observed by scanning the excitation spectrum between 300 
and 400 nm, while monitoring the emission at ~510 nm (invitrogen.com).  In these 
experiments the Fura-2 was excited by exposing it to both 340 nm and 380 nm 
wavelengths of light while monitoring emissions at 510 nm.  Calculations made by 
looking at the ratios of emitted light evoked by 340 nm/380 nm excitation allowed for 
us to determine the intracellular concentration of calcium at specific instances in time 
(see formula below): 
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Figure 4 
Fluorescence emission of Fura-2 at differing wavelengths.  This graph indicates the 
difference in fluorescence of Fura-2 due to the excitation wavelength and intracellular 
free-calcium concentrations.  The dye was excited at wavelengths indicated on the X 
axis.  When the intracellular calcium level is zero, the fluorescence intensity at 340 nm 
is less than that at 380 nm when viewed at 510 nm.  As the free calcium level increases, 
the fluorescence intensity at 340 nm increases as the fluorescence intensity at 380 nm 
decreases when viewed at 510 nm.   
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[Ca] = Kd (Sf2/Sb2)(Rexp - Rmin/Rmax-Rexp) 
Kd = 224 x 10-9 M 
Sf2 = intensity 380 nm Ca free 
Sb2 = intensity 380 nm Ca saturated  
 
Rexp = measured experimental ratio 
Rmin = 0 Ca ratio 
Rmax = Ca saturated ratio 
 
 
 Thus the measured experimental ratio is directly proportional to the calcium 
concentration within the cell and can be calculated by calibrating the system using a 0 
mM Ca2+ solution and a saturating Ca2+ solution (typically 5 mM).  Additionally, by using 
two different wavelengths of light to measure concentration, variables, such as dye 
bleaching and cell thickness, can be cancelled out preventing unwanted artifact.  In this 
thesis all fluorescent values are given as ratio units rather than Ca2+ concentrations.  
Previous students in the Wyatt laboratory have not been able to acquire satisfactory 
Sb2 readings to allow accurate calibration. 
 
Ca2+ IMAGING 
 Cells were visualized with a Nikon TE2000U inverted microscope with a CFI 
super fluor x40 oil immersion objective.  Fura-2 was excited with 50 msec exposures to 
340 nm and 380 nm light at 0.2 – 0.5 Hz using a Lambda 10 – 3 filter wheel (Sutter) and 
emitted fluorescence measured at 510 nm using a CoolSNAP HQ2 CCD camera.  Light 
was provided by a Lambda-LS xenon arc lamp (175 watt, Sutter).  Because of the 
extremely high wattage of this lamp, the light was first passed through neutral density 
filters of 0.7 optical densities (Chroma, USA) before reaching cellular specimens to 
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prevent any photodamage to the cells (Burlon et al, 2009).  Neutral density filters are 
capable of decreasing the intensity of light from all wavelengths equally, therefore 
lowering the power of light from the source.   
Data acquisition and analysis was controlled using Metafluor 7.1.2 imaging 
software (Molecular Devices).  340/380 ratio images were generated on-line and time 
courses showing changes in the fluorescence ratio assessed by placing regions of 
interest over the type I cell images.  Only cells that responded to an 80 mM K+ challenge 
(KCl replaced NaCl in equimolar amounts, 80 mM KCl was used to evoke maximal Ca2+ 
influx) with a rapid, robust, and reversible increase in fluorescence ratio were selected 
for study.   
 
PERFUSION OF ISOLATED TYPE I CELLS 
 Isolated cells, plated on round coverslips, were placed into the perfusion 
chamber (0.4 ml) and washed with HEPES buffered saline solution (34 – 36° C) for 
approximately 5 – 7 minutes.  Temperatures were maintained at 34 – 36° C by passing 
solutions through an in-line heater (SH-27F, Warner Instruments, USA) which was 
feedback controlled by an automatic temperature controller (TC-344B, Warner 
Instruments, USA). 
 The dissociation procedure used here yields predominantly individual, isolated 
type I cells.  Occasionally clusters of cells were observed, but these were not recorded 
from as locally released neurotransmitters within the cluster would confuse any results 
obtained.  Regions of interest (ROI) were drawn over isolated cells using Metafluor 
software, and the calcium signal was taken as the average within the ROI, data were 
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background subtracted (using an ROI placed over a region where there were no cells to 
obtain background signal).  Changes in the calcium signal were measured from the 
baseline (average of three exposures immediately prior to drug exposure) to the peak 
response during exposure.  Only cells that responded to KCl exposure, recovered to 
baseline within three minutes, showed no spontaneous Ca2+ spiking and had level 
baselines that did not rise throughout the recording were used in this study.  A 
complete recovery from the KCl challenge had to occur to ensure that the Ca2+ handling 
machinery of the type I cells were healthy.  Recordings from individual cells represents 
n = 1.  Compounds were only ever applied once to a coverslip of cells to avoid the 
possibility of any desensitization or sensitization occurring.   
 Solution changes were accomplished by switching the solution inflow to a 
chamber containing the solution of choice; all solutions were perfused by gravity.  
Solution exchange in the chamber was usually complete within 5 seconds. 
 
STATISTICAL SIGNIFICANCE 
 Data are presented as means  standard error of the mean.  Differences between 
individual means were determined by unpaired Student’s t-test.  A value of P < 0.05 was 
taken to indicate statistical significance.   
 
CHEMICALS 
The drugs used in this research are included in Table 1. 
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Table 1 
Compound Target Source 
Acetyl- -methylcholine chloride muscarinic receptor agonist Sigma 
Histamine dihydrochloride histamine receptor agonist Sigma 
(R)-(-)- -methylhistamine 
dihydrobromide 
H3 receptor agonist Tocris 
SQ 22536 adenylate cyclase inhibitor Tocris 
H89 PKA inhibitor Tocris 
KT 5720 PKA inhibitor Tocris 
Brefeldin A Epac inhibitor Tocris 
8-pCPT-2’-O-Me-cAMP AM 
 
Epac agonist Biolog 
 
Compound Concentration (vehicle) Exposure 
Acetyl- -methylcholine chloride 100 µM (extracellular soln’) 30 sec 
Histamine dihydrochloride 300 µM (extracellular soln’) 2 min 
(R)-(-)- -methylhistamine 
dihydrobromide 
30 nM (extracellular soln) 2 min 
SQ 22536 100 µM (extracellular soln’) 5 min 
H89 10 µM (0.1% DMSO) 2 min 
KT 5720 1 µM (0.1% DMSO) 2 min 
Brefeldin A 100 µM (1% DMSO) 6 min 
8-pCPT-2’-O-Me-cAMP AM 
 
1 – 3 µM (0.1-0.3% DMSO) 6 min 
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III:  RESULTS 
 
 A concentration of 80mM K+ was applied to cells to ensure that they were both 
living and viable.  Only cells that responded with a rapid, robust, and reversible rise in 
[Ca2+]i were selected for study.  Thus cells were selected with intact calcium entry 
mechanisms and healthy calcium handling properties.  To avoid the possibility that type 
I cells released neurotransmitters that could act upon their immediate neighbors and 
confuse interpretation of data, clusters of three or more cells were not used in this 
study.   
 
EFFECT OF METHYLCHOLINE ON [Ca2+]i 
 Methylcholine has been shown to increase [Ca2+]i by releasing calcium from  
intracellular stores and by allowing calcium to enter from outside the cell (Dasso et al, 
1997).  The muscarinic agonist acetyl- -methylcholine (MC, 100 m, submaximal 
concentration (Dasso et al, 1997)) evoked maximal calcium signaling responses of 0.40 
 0.04 ratio units (R.U.) in 63.2% of isolated type I cells examined after a 30 second 
challenge (n = 38, Fig. 5 A and B).  The response was often seen immediately after the 
drug reached the cell, but sometimes the response was delayed by seconds.  The 
calcium ratio returned to baseline, and occasionally, spiking responses were seen after 
the removal of MC.   
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Figure 5 
Inhibitory effect of histamine on muscarinic receptor induced calcium signaling in rat 
carotid body type I cells.  A.  An example trace of the fluorescence ratio when an isolated 
type I cell is exposed to acetyl- -methylcholine (MC, 100 m, 30 sec).  K indicates 
exposure to a high potassium solution (80 mM).    B.  A histogram showing  
the percentage of type I cells that responded to MC (63.2%) and to MC in the presence 
of histamine dihydrochloride (H, 300 M, 53.0%).  C.  An example trace of the 
fluorescence ratio when a type I cell is exposed to MC (100 M) in the presence of H 
(300 M).  D.  A histogram indicating the average magnitude of the response of type I 
cells to MC (0.401 R.U.) and to MC in the presence of H (0.122 R.U.).  ** indicates 
statistical significance (p < 0.003). 
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EFFECT OF HISTAMINE ON [Ca2+]i 
 The application of histamine did not have an effect on [Ca2+]i  in isolated type I 
cells (Burlon et al, 2009).  Therefore, histamine was tested to see if it could modulate 
the actions of an excitatory stimulus.  As shown in Fig. 5, MC caused rises  
in [Ca2+]i in type I cells and has previously been shown to be excitatory (Dasso et al, 
1997, Ortiz and Varas, 2010).  The histaminergic agonist histamine dihydrochloride 
(300 M, maximal concentration (Burlon et al, 2009)) was applied for 60 seconds prior 
to a co-application of MC (100 M).  The MC-induced calcium response in the presence 
of histamine was significantly reduced (p < 0.003) to an average of 0.12  0.04 R.U (Fig. 
5 C and D).  In these same conditions, only 53.0% of the isolated type I cells responded 
(n = 17, Fig. 5 B).   
EFFECT OF THE H3 RECEPTOR AGONIST ON [Ca2+]i 
 Since the histamine attenuated the MC response, the next step was to determine 
through which receptor histamine was acting.  Type I cells express Gi proteins coupled 
to the H3 receptor (Burlon et al, 2009, Lazarov et al, 2006).  Using the H3 specific 
agonist, (R)-(-)- -methylhistamine dihydrobromide at a concentration of 30 nM (60 sec 
prior to the 100 M 30 sec co-application of MC), the MC response was significantly 
reduced to 0.06  0.01 R.U (n = 9, p < 0.003, Fig. 6 B, C, and D).     
 
EFFECT OF THE ADENYLATE CYCLASE INHIBITOR 
 The mechanisms by which H3 receptor activation inhibited MC induced Ca2+ 
signaling are not known.  However, Gi coupled receptors exert their actions via the  
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Figure 6 
Inhibitory effect of a selective histamine H3 agonist on muscarinic receptor induced 
calcium signaling in rat carotid body type I cells. A.  An example trace of the 
fluorescence ratio when an isolated type I cell is exposed to acetyl- -methylcholine (MC, 
100 m, 30 sec).  K indicates exposure to a high potassium solution (80 mM).    B.  A 
histogram marking the percentage of type I cells that responded to MC (63.2%) and to 
MC in the presence of (R)-(-)- -methylhistamine dihydrobromide (H3, 30 nM, 55.5%).  
C.  An example trace of the fluorescence ratio when a type I cell is exposed to MC (100 
M) and H3 (30 nM).  D.  A histogram indicating the average magnitude of the response 
of type I cells to MC (0.401 R.U.) and to MC in the presence of H3 (0.060 R.U.).  ** 
indicates statistical significance (p < 0.003). 
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inhibition of adenylate cylase, which prevents the accumulation of cAMP.  The drug SQ 
22536 (SQ), an adenylate cyclase inhibitor, was therefore co-applied with MC to 
determine if its effects mimicked those of the H3 specific agonist.  SQ (100 M, 4  
min) also significantly inhibited the average magnitude of the response to 0.17  0.04 
R.U as did the activation of the H3 receptor (p < 0.02, Fig. 7 C and D).  In the presence of 
SQ, the percentage of cells that responded to MC was reduced to 44.4% (n = 18, Fig. 7 
B). 
 
EFFECT OF THE PROTEIN KINASE A INHIBITORS 
 Inhibition of adenylate cyclase mirrored the effects seen with the activation of 
the H3 receptor.  It was therefore investigated whether inhibiting the activity of protein 
kinase A (PKA) was responsible for this.  Inhibition of adenylate cyclase will attenuate 
production of cAMP.  This in turn will inhibit any constitutive activity of PKA.  Inhibition 
of PKA has been shown to activate K+ leak channels, and therefore, oppose 
depolarization and calcium entry in type I cells (Xu et al, 2007). Thus activation of Gi-
coupled receptors may potentially inhibit Ca2+ signaling in type I cells by an inhibitory 
action on PKA. 
 The first PKA inhibitor used was H89 (10 M, 60 sec).  The drug did not have any 
significant effect on the average magnitude of the MC response or in the number of cells 
that responded to MC (Fig. 8 C).  64.7% of the cells responded to MC with an average 
response of 0.35  0.07 R.U. (n = 17, Fig. 8 B and D). Importantly, it has previously been 
shown that application of H89 at this concentration inhibited PKA (Xu et al, 2007). 
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Figure 7 
Inhibitory effect of the adenylate cyclase inhibitor SQ22536 on muscarinic receptor 
induced calcium signaling in rat carotid body type I cells.  A.  An example trace of the 
fluorescence ratio when an isolated type I cell is exposed to acetyl- -methylcholine (MC, 
100 m, 30 sec).  K indicates exposure to a high potassium solution (80 mM).    B.  A 
histogram marking the percentage of type I cells that responded to MC (63.2%) and to 
MC in the presence of SQ 22536 (SQ, 100 M, 44.4%).  C.  An example trace of the 
fluorescence ratio when a type I cell is exposed to MC (100 M) and SQ (100 M).  D.  A 
histogram indicating the average magnitude of the response of type I cells to MC (0.401 
R.U.) and to MC in the presence of SQ (0.173 R.U.).  ** indicates statistical significance (p 
< 0.02). 
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Figure 8 
PKA inhibition does not significantly attenuate muscarinic receptor induced calcium 
signaling in rat carotid body type I cells.  A.  An example trace of the fluorescence ratio 
when an isolated type I cell is exposed to acetyl- -methylcholine (MC, 100 m, 30 sec).  
K indicates exposure to a high potassium solution (80 mM).    B.  A histogram showing 
the percentage of type I cells that responded to MC (63.2%) and to MC in the presence 
of H89 (10 M, 64.7%).  C.  An example trace of the fluorescence ratio when a type I cell 
is exposed to MC (100 M) and H89 (10 M).  D.  A histogram indicating the average 
magnitude of the response of type I cells to MC (0.401 R.U.) and to MC in the presence of 
H89 (0.350 R.U.).   
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To ensure that PKA inhibition actually had no role in attenuating the MC response, a 
second PKA inhibitor was used, KT 5720 (1 M, 60 sec).  Again, the PKA inhibitor was 
unable to mimic the effects of the activation of the H3 receptor (Fig. 9 C).  The KT 
compound reduced the average magnitude of response to 0.26  0.04 R.U. (n = 27, Fig. 9 
D) with 48.10% of type I cells responding (Fig. 9 B), however, these results were not 
significantly different from control MC responses.   
 
A RECENTLY DISCOVERED PATHWAY:  EXCHANGE PROTEINS ACTIVATED BY cAMP 
 Since the two PKA inhibitors were unable to significantly reduce the excitatory 
effects of MC, a mechanism independent of PKA was potentially responsible for 
inhibiting muscarinic receptor mediated calcium signaling.  Exchange Proteins 
Activated by cAMP (Epac) mediate PKA independent signal transduction properties of 
cAMP (Bos, 2003).  Activation of Epac has been shown to mediate changes in 
intracellular calcium (Holz et al, 2006).    
 Therefore, a non-selective Epac inhibitor was used to see if the inhibition of Epac 
mimicked the effects of H3 receptor activation.  The drug, Brefeldin A (BFA, 100 M, 
(Rocher et al, 2009)) was applied 5 minutes prior to the application of MC (Fig. 10 C).  
BFA significantly reduced the average magnitude of the calcium response to 0.14  0.04 
R.U. (p < 0.02, Fig. 10D) with only 50.0% of the type I cells responding (n = 12, Fig. 10 
B).  It was noted that in 92% of the cells that were tested a rise in baseline calcium was 
seen with the application of BFA prior to MC exposure (Fig. 10 C).  The rise was small 
but observed repeatedly with an average magnitude of 0.06 R.U.   
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Figure 9 
PKA inhibition does not significantly attenuate muscarinic receptor induced calcium 
signaling in rat carotid body type I cells.  A.  An example trace of the fluorescence ratio 
when an isolated type I cell is exposed to acetyl- -methylcholine (MC, 100 m, 30 sec).  
K indicates exposure to a high potassium solution (80 mM).  B.  A histogram marking 
the percentage of type I cells that responded to MC (63.2%) and to MC in the presence 
of KT 5720 (KT, 1 M, 48.1%).  C.  An example trace of the fluorescence ratio when a 
type I cell is exposed to MC (100 M) and KT (1 M).  D.  A histogram indicating the 
average magnitude of the response of type I cells to MC (0.401 R.U.) and to MC in the 
presence of KT (0.259 R.U.).   
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Figure 10 
Inhibition of Exchange Proteins Activated by cAMP (Epac) significantly inhibited the 
muscarinic receptor induced calcium signaling in rat carotid body type I cells.  A.  An 
example trace of the fluorescence ratio when an isolated type I cell is exposed to acetyl-
-methylcholine (MC, 100 m, 30 sec).  K indicates exposure to a high potassium 
solution (80 mM).    B.  A histogram marking the percentage of type I cells that 
responded to MC (63.2%) and to MC in the presence of brefeldin A  (BFA, 100 M, 
50.9%).  C.  An example trace of the fluorescence ratio when a type I cell is exposed to 
MC (100 M) and BFA (100 M).  D.  A histogram indicating the average magnitude of 
the response of type I cells to MC (0.401 R.U.) and to MC in the presence of BFA (0.141 
R.U.).  ** indicates statistical significance (p < 0.02).   
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 Since BFA is not a selective Epac inhibitor and may influence Ca2+ signaling by 
multiple mechanisms (see dicussion, (Holz et al, 2006)), a known Epac activator was 
used to determine if activation of Epac could modulate MC induced Ca2+ signaling.  8-
pCPT-2’-O-Me-cAMP AM is a potent membrane permeable Epac activator (Vliem et al, 
2008).  It was applied for 5 minutes at a concentration of 1 M prior to the co-
application of MC at 100 M (Fig. 11 C).  The MC response was 0.46  0.07 R.U. (n = 29, 
Fig. 11 D) in 48.3% of isolated type I cells; however, this was not a significant increase 
in magnitude.  8-pCPT-2’-O-Me-cAMP is a new compound, and there are few 
publications where it has been applied to isolated cells (Vliem et al, 2008).  The effects 
of 8-pCPT-2’-O-Me-cAMP AM (3 µM) on MC evoked Ca2+ signaling were therefore 
examined.  A five-minute pre-application with the higher dose caused a significant 
increase in the average magnitude 0.97 ± 0.24 (n = 11, p < 0.004, Fig. 12) with 54.5% of 
the cells responding to MC.  
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Figure 11 
Low dose activation of Epac does not potentiate the effects of muscarinic receptor 
induced calcium signaling in rat carotid body type I cells.  A.  An example trace of the 
fluorescence ratio when an isolated type I cell is exposed to acetyl- -methylcholine (MC, 
100 m, 30 sec).  K indicates exposure to a high potassium solution (80 mM).    B.  A 
histogram marking the percentage of type I cells that responded to MC (63.2%) and to 
MC in the presence of 8-pCPT-2’-O-Me-cAMP AM (x-cAMP, 1 M, 48.3%).  C.  An 
example trace of the fluorescence ratio when a type I cell is exposed to MC (100 M) 
and x-cAMP (1 M).  D.  A histogram indicating the average magnitude of the response 
of type I cells to MC (0.401 R.U.) and to MC in the presence of x-cAMP (0.463 R.U.).  
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Figure 12 
Higher dose activation of Epac potentiates the muscarinic receptor induced calcium 
signaling in rat carotid body type I cells.  A histogram indicating the average magnitude 
of the fluorescent response of type I cells to acetyl- -methylcholine chloride (MC, 0.401 
R.U.) to MC in the presence 8-pCPT-2’-O-Me-cAMP AM (x-cAMP, 1 M, 0.463 R.U.), and 
to MC in the presence x-cAMP (3 M, 0.968 R.U.)  **indicates statistical significance (p < 
0.005). 
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IV:  DISCUSSION 
 
 
 
 These data demonstrate that two neurotransmitters released from the carotid 
body type I cells by chemostimuli can functionally interact.  Both acetylcholine (ACh) 
and histamine are released by the rat carotid body (Koerner et al, 2004, Eyzaguirre and 
Zapata, 1968) with ACh being excitatory presynaptically via action on both muscarinic 
and nicotinic receptors (Dasso et al, 1997, Wyatt and Peers, 1993), and histamine being 
without any excitatory presynaptic activity in isolated cells (Burlon et al, 2009).  The 
data presented in this study indicate that histamine, acting via autoinhibitory H3 
receptors, can inhibit calcium signaling initiated by the activation of muscarinic ACh 
receptors.   
 Thus the hypothesis that histaminergic and muscarinic signaling can interact in 
the carotid body type I cells is correct.  However, the interaction inhibited rather than 
potentiated the muscarinic Ca2+ signal, and as a result, it is unlikely that this mechanism 
can explain why histamine appears to be excitatory in the intact carotid body (Lazarov 
et al, 2006).   
 Furthermore, these data define the potential mechanism by which histamine 
inhibits muscarinic receptor-induced Ca2+ signaling in rat carotid body type I cells.  The 
inhibition of adenylate cyclase, such as would be seen during activation of Gi-coupled 
histamine H3 receptors, inhibits muscarinic receptor-activated Ca2+ signaling in isolated 
type I cells (Fig. 7).  Inhibition of adenylate cyclase leads to a decrease in the generation 
of cAMP and, therefore, inhibition of PKA (Glass and Krebs, 1980).  It has been 
previously been hypothesized that regulation of PKA could perhaps modulate Ca2+ entry 
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into type I cells by activation or inhibiting TASK channels and hyperpolarizing or 
depolarizing cells (Xu et al, 2007).  However, this was unlikely to mediate the 
histamine-induced inhibition of muscarinic receptor induced Ca2+ signaling as 
histamine does not inhibit depolarization-induced Ca2+ entry in type I cells (Burlon et al, 
2009).  Indeed it is now shown here that PKA inhibitors have no effect on the 
muscarinic receptor-activated Ca2+ signaling in isolated type I cells (Fig. 8 and 9).  These 
experiments suggest that the inhibitory effect of histamine on rises in [Ca2+]i and the 
similar effects of muscarinic Ca2+ signaling seen with inhibition of adenylate cyclase by 
SQ22536 (Fig. 7) cannot be mediated by PKA.   
 Evidence now suggests that 100 M methylcholine (as used in this study) 
induces a rise in [Ca2+]i that is predominantly driven by release of Ca2+ from 
intracellular stores in carotid body type I cells (Ortiz and Varas, 2010).  Inhibition of 
adenylate cyclase, and hence a reduction in cAMP, must somehow interact with the 
muscarinic receptor-induced release of Ca2+ causing it to be attenuated.  There is 
evidence that the cAMP-activated Epac family of exchange factors are involved in 
mobilizing Ca2+ from intracellular stores (Kang et al, 2003).  Additionally it has been 
postulated that Epac may sensitize Ca2+ release channels such as the IP3 receptor to 
their endogenous ligands (Holz et al, 2006).  It was therefore conceivable that if a fall in 
cAMP inhibited endogenous Epac activity, Ca2+ stores would become less sensitive to IP3 
liberated during Gq-coupled muscarinic receptor stimulation.  Thus if Epac could be 
inhibited pharmacologically, the effects of inhibition of adenylate cyclase would be 
reproduced (i.e., inhibition of muscarinic Ca2+ would occur).  Furthermore, if Epac was 
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stimulated pharmacologically, the reverse should be seen, and the Ca2+ signal following 
muscarinic receptor activation should be enhanced in the presence of an Epac agonist.   
 To test this hypothesis, the putative Epac inhibitor brefeldin A (BFA) was 
applied to type I cells prior to a methylcholine challenge.  The Ca2+ response to 
methylcholine was inhibited in the presence of BFA (Fig. 10).  However, BFA also 
caused an additional transient rise in Ca2+ when perfused over the cells.  It is known 
that in addition to inhibiting Epac, BFA causes retraction of the Golgi apparatus in cells 
(Dinter and Berger, 1998).  Therefore, the small transient Ca2+ response seen upon 
application of BFA may be a result of BFA releasing Ca2+ from the Golgi apparatus 
(Vanoevelen et al, 2005).  If this is the case, then BFA may not be inhibiting muscarinic 
receptor activated Ca2+ signaling by an inhibitory action on Epac.  IP3 receptors are 
present on the Golgi apparatus ((Pinton et al, 1998), and as such, Gq-coupled 
muscarinic receptors may release Ca2+ from the Golgi.  If BFA has disrupted this store 
and caused it to be depleted of Ca2+, then the muscarinic Ca2+ signals would be reduced.  
Importantly, even when [Ca2+]i is monitored carefully, an effect of BFA on cell Ca2+ 
signaling cannot be attributed solely to its effect on Epac (Vanoevelen et al, 2005). 
 Due to this uncertainty over the specificity of BFA for Epac, a new membrane 
permeant selective Epac agonist 8-pCPT-2’-O-Me-cAMP AM was used to examine the 
Epac hypothesis (Vliem et al, 2008).  This compound should activate Epac, and in theory 
may sensitize Ca2+ stores to IP3.  Consequently, Ca2+ signals evoked by Gq-coupled 
muscarinic receptors on the type I cells should be enhanced.  A five-minute exposure to 
8-pCPT-2’-O-Me-cAMP AM (3 M) did augment the Ca2+ responses to methylcholine 
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(Fig. 12).  Thus Epac may be involved in regulating intracellular Ca2+ release in type I 
cells.   
 
FUTURE EXPERIMENTS 
 Future studies aim to examine the mechanism by which inhibition of Epac 
inhibits Ca2+ signaling.  The first method to do this would be to use caged IP3 to perfuse 
over the isolated type I cells.  Caged IP3 is IP3 that has been modified so that it is inactive 
and membrane permeable (Rainbow et al, 2009).  Once the caged IP3 has crossed the 
cell membrane, it is exposed to UV light to activate the IP3.  Then a Ca2+ signal can be 
measured.  If the Ca2+ signal is enhanced in the presence of an Epac activator, then Epac 
can presumably sensitize the IP3 receptors to their ligand (IP3).   
 The effects of the Epac activator on signaling via a different Gq-coupled receptor 
could also be studied.  For example, the 5-HT2 serotonin receptor subtypes are located 
on the surface of type I cells (Zhang et al, 2003) and their activation is excitatory.  
Activation of these receptors will initiate similar signaling pathways to the type I cell 
muscarinic receptors and the modulatory effects of Epac on this signaling could also be 
examined. These experiments will not reveal the mechanism by which Epac is working 
but will reveal if it can modulate the signaling of multiple receptor types rather than 
muscarinic receptors alone.    
 
CONCLUSION 
 Carotid body type I cells release a number of neurotransmitters, such as 
acetylcholine and histamine, in response to adverse arterial blood chemostimuli.  This 
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work shows that these two neurotransmitters can interact with one another to affect 
the [Ca2+]i  levels of type I cells (Fig. 13).   Activation of muscarinic receptors causes a 
rise in [Ca2+]i due to the liberation of Ca2+ by way of IP3 from intracellular stores;  
however, if both muscarinic and histaminergic receptors are stimulated simultaneously, 
the Ca2+ signal is significantly attenuated.  The inhibitory effects of histamine were 
shown to be functioning via H3 receptor activation.  These Gi-coupled receptors work 
by inhibiting the activation of adenylate cyclase and therefore the accumulation of 
cAMP.  Instead of functioning in a PKA-dependent manner, the inhibition due to H3 
receptor activation is most likely due the inhibition of Exchange Proteins Activated by 
cAMP (Epac).  Therefore, Epac may be functioning to sensitize IP3 receptors on the 
surface of intracellular stores to release calcium.  Further work needs to be completed 
to determine the precise role Epac plays in this mechanism. Critically, experiments need 
to be performed in cells that are actively responding to a chemostimulus. By studying 
these active cells rather than quiescent cells we will be able to determine the 
importance of the signaling pathways defined in this thesis during chemotransduction. 
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Figure 13 
A schematic demonstrating how the activation of histaminergic and muscarinic 
receptors affect intracellular calcium levels.  The activation of the cell membrane 
muscarininc receptor (M) is Gq-coupled and therefore activates Gq.  This leads to the 
activation of phospholipase C (PLC).  The activation of PLC causes the cleavage of 
phosphatidyl 4,5-biphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3) and 
diacylglycerol (DAG).  IP3 binds to its receptor (IP3R) located on the membrane of 
intracellular stores, which will cause the release of calcium.  The activation of the Gi-
coupled H3 receptor will inhibit the activation of adenylate cyclase, the accumulation of 
cAMP, and the activation of Epac.  The inhibition of Epac will prevent the IP3R from 
being sensitized, and therefore will not allow for an increase in intracellular calcium 
due to the release from intracellular stores. 
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